Article

OBJECTIVE: To compare the treatment efficacy between corticosteroid injection and
nonsteroidal anti-inflammatory drugs (NSAIDs) for patients with shoulder pain.
DATA SOURCES: PubMed and EMBASE databases were searched from inception to January 2014. Reference lists of the retrieved studies were additionally scrutinized.
STUDY SELECTION: Randomized controlled trials (RCTs) comparing corticosteroid
injection with NSAIDs for treatment of shoulder pain were included. The primary
outcome was remission, and the secondary outcomes were pain relief and
improvement of range of active abduction. Study selection was conducted by 2
researchers independently. Any disagreements were solved by discussion and
confirmed by the third reviewer. DATA EXTRACTION: Two reviewers independently
conducted data extraction and the quality assessment. Data regarding patients,
intervention, control, and outcomes were extracted from the included trials. DATA
SYNTHESIS: Six high-quality RCTs of 267 patients meeting the inclusion criteria
were included. For an outcome of remission, NSAIDs were less effective than
corticosteroid in 4 or 6 weeks (relative risk, .64; 95% confidence interval,
.45-.92). NSAIDs did not significantly differ with corticosteroid in pain relief
and improvement of range of active abduction. CONCLUSIONS: Current meta-analysis
suggests that NSAIDs are less effective than corticosteroid in achieving
remission in patients with shoulder pain at 4 or 6 weeks after treatment.
Considering the limited number of studies and small size of each trial, the
results should be interpreted with caution, and more high-quality RCTs are encouraged.
CI - Copyright (c) 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Langue : ANGLAIS